Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.06.23 | Molecure - OATD-01 gearing up for Phase II | 400 | Edison Investment Research | Molecure has filed an Investigational New Drug (IND) application with the US FDA for OATD-01. Clearance of the application will enable the company to initiate a global (US and EU), multi-centre, randomised... ► Artikel lesen | |
26.06.23 | OSE Immunotherapeutics - New diagnostic test to support Tedopi trial | 438 | Edison Investment Research | OSE Immunotherapeutics (OSE) has received €1.5m in non-dilutive funding from Bpifrance (a French public sector investment bank) to develop a companion diagnostic test to support the upcoming Phase III... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 345 |
EVOTEC | 314 |
TUI | 228 |
NVIDIA | 191 |
DEUTSCHE BANK | 183 |
BAYER | 170 |
PLUG POWER | 153 |
NEL | 141 |
RHEINMETALL | 139 |
SIEMENS ENERGY | 123 |
COMMERZBANK | 113 |
BARRICK GOLD | 112 |
BASF | 110 |
TESLA | 109 |
VOLKSWAGEN | 100 |
RWE | 99 |
BYD | 95 |
DEUTSCHE LUFTHANSA | 92 |
ALLIANZ | 90 |
DEUTSCHE TELEKOM | 87 |
MERCEDES-BENZ | 86 |
RENK GROUP | 84 |
E.ON | 80 |
HEIDELBERGER DRUCK | 79 |
AIXTRON SE | 76 |